Blogs - Page 28 of 136 - This Week In Public Health

Global

Exploring Alternatives to Hormone Replacement Therapy for Menopause

This week, an exciting development in women’s health took the spotlight with the introduction of a new non-hormonal daily pill as an alternative to Hormone Replacement Therapy (HRT) for managing menopausal symptoms such as hot flushes. As per the report by BBC Health, this new treatment could potentially benefit around 500,000 women in the UK […]

Read more →

Funding

NIH Funding Is Growing—But Access Is Shrinking

NIH Funding Is Growing—But Access Is Shrinking: What FY2025 Data Means for Public Health The latest NIH funding data suggests progress at first glance. In fiscal year 2025, the agency awarded $35.3 billion in extramural research grants, marking a modest increase over prior years. This continued investment reinforces the federal government’s stated commitment to biomedical […]

Read more →

Analytics

Why Your Statistical Model Might Be Misleading You (And What Public Health Practitioners Should Do About It)

Public health decisions depend on data. But what if the way we analyze that data is quietly leading us in the wrong direction? A recent commentary highlights a surprisingly common issue in public health research: many studies use the wrong statistical models—or interpret them incorrectly—when working with simple yes/no outcomes like depression, substance use, or […]

Read more →

Health equity

Rising Tide: The Surge in Cardiovascular Disease Rates Among U.S. Women

The United States has witnessed a worrying surge in the rates of cardiovascular disease (CVD) among women. This trend not only poses a significant public health challenge but also serves as a clarion call to reevaluate the underlying causes and the far-reaching consequences for individuals and the healthcare system at large. Understanding the Surge Research […]

Read more →

Policy

Cutting T2D Rates: Proven Impact of SSB Policies

Imagine a bustling community center where health advocates are testing a new strategy: graphic warning labels on sugar-sweetened beverages (SSBs). As community members examine these boldly labeled drinks, conversations spark about sugar intake and health implications, highlighting an everyday challenge in public health. This scenario brings to life a pivotal question: what are the most […]

Read more →

Interview

Protected: A conversation with Jennifer Karlin, MD, PhD

There is no excerpt because this is a protected post.

Read more →

Quality

F.D.A. Faces Community Backlash Over Drug Denials

The U.S. Food and Drug Administration (F.D.A.) has been at the forefront of public health initiatives, playing a critical role in ensuring drug safety and efficacy. Recent events, however, have spotlighted the agency amid a storm of public dissent and policy scrutiny. At the center of this controversy is the F.D.A.’s decision to reject several […]

Read more →

Commentary

The “Research–Practice Gap” in Implementation Science: A Problem We May Have Created Ourselves

For decades, implementation science has tried to answer a simple but stubborn question: Why does it take so long for research to improve real-world practice? In healthcare, education, and social services, researchers often produce powerful evidence—but practitioners struggle to apply it consistently. A new commentary published in Global Implementation Research and Applications argues something surprising: […]

Read more →

Policy

Hidden Costs of Justice: LFOs and Health Implications

Consider a single mother in rural America who receives a traffic ticket. She’s faced with court fees that she can barely afford. Juggling two jobs and worrying about feeding her children, she’s now burdened with a compounding legal debt. These legal financial obligations, or LFOs, push her further into the cycle of poverty, a situation […]

Read more →